Almirall (WBO:ALM) Pre-Tax Income : €27.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Almirall Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Almirall's pretax income for the three months ended in Mar. 2024 was €15.1 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €27.8 Mil. Almirall's pretax margin was 6.07%.

During the past 13 years, Almirall's highest Pretax Margin was 58.85%. The lowest was -50.21%. And the median was 8.66%.

Almirall Pre-Tax Income Historical Data

The historical data trend for Almirall's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Pre-Tax Income Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

128.28

79.24

-9.09

31.03

-17.19

Almirall Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-	15.40	12.72	-	15.10

Competitive Comparison of Almirall's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Almirall's Pre-Tax Income falls into.

Almirall Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Almirall's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	45.497	+	0	+	-7.208	+	5.585	+	-61.065
	=	-17.2

Almirall's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-15.5	+	0	+	-2.8	+	0	+	33.4
	=	15.1

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €27.8 Mil.

Almirall (WBO:ALM) Pre-Tax Income Explanation

Almirall's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	15.1	/	248.8
	=	6.07%

During the past 13 years, Almirall's highest Pretax Margin was 58.85%. The lowest was -50.21%. And the median was 8.66%.

Almirall Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Almirall's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (WBO:ALM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (WBO:ALM) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (WBO:ALM) Headlines

From GuruFocus

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar • 05-07-2021

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar • 06-02-2021